<
 / Physicians

Clinical Conundrums IV: 2019 Update

Start Date
End Date
Add to my calendar 2019-06-13 18:30:00 2019-06-13 20:30:00 Clinical Conundrums IV: 2019 Update Overview: Please join us for a contemporary and clinically relevant educational activity which has been specifically designed to address the most frequently encountered clinical challenges in the management of patients with Atrial Fibrillation and the related co-morbidities in the primary care setting. This activity was developed by leading Canadian Experts to provide clinicians with answers to frequently asked questions and key take-away messages that can be applied to real-world practice. Agenda: Upon completion of this activity, participants should be able to: Select personalized treatment options for stroke prevention in atrial fibrillation using current Canadian Practice Guidelines supplemented with reassuring “Real World” experience. Assess and optimize bleeding risk of atrial fibrillation patients requiring long-term DOAC stroke prevention treatment. Recognize the current treatment gap in Canada and take steps at ensuring appropriate dosage selection and long-term compliance with oral anticoagulation among AF patients. Case 9: Optimizing the Use and Dosing of DOACs in Patients with AF: Upon completion of this activity, participants should be able to: Apply the rationale for the appropriate use and non-use of community-based observational data (real-world data) in clinical practice. Discuss real-world treatment patterns with OAC therapy. Effectively manage the use and dosing of OAC therapy in patients with AF Date: Thursday, June 13, 2019 Location: North 54, 1493 3rd Avenue, Prince George, BC Speaker: Dr. Philip Teal Moderator: Dr. Haidar Hadi Registration: 6:30 pm (dinner to follow) RSVP: Val Bernales, Phone: 604-679-3066 Email: val.bernales@pfizer.com Accreditation: This one-credit-per-hour Group Learning program has been certified by the College of Family Physicians of Canada and the British Columbia Chapter for up to 1.50 Mainpro+ credits. This program has received an educational grant and in-kind support from BMS/Pfizer Alliance Canada Disclaimer: The CME Event Calendar contains information originating from other sources. While every attempt is made to ensure that all information is accurately referenced, we do not guarantee the accuracy, quality or CME accreditation of posted events. Before registering for this event, please refer to the provincially harmonized CME Policy regarding reimbursement requirements for courses and conferences. North 54 1493 3rd Avenue Prince George V2L 3G1 Canada Physician Education physician.education@northernhealth.ca America/Vancouver public
Add to Calendar: Start date 2019-06-13 18:30:00 2024-04-24 09:06:36 Title Description Location Physicians rajbir.singh@opin.ca America/Vancouver public
Add to Calendar: End Date 2024-04-24 09:06:36 2019-06-13 20:30:00 Clinical Conundrums IV: 2019 Update Clinical Conundrums IV: 2019 Update North 54 1493 3rd Avenue Prince George V2L 3G1 Canada Physicians rajbir.singh@opin.ca America/Vancouver public

Overview: Please join us for a contemporary and clinically relevant educational activity which has been specifically designed to address the most frequently encountered clinical challenges in the management of patients with Atrial Fibrillation and the related co-morbidities in the primary care setting. This activity was developed by leading Canadian Experts to provide clinicians with answers to frequently asked questions and key take-away messages that can be applied to real-world practice.

Agenda:

Upon completion of this activity, participants should be able to:

  1. Select personalized treatment options for stroke prevention in atrial fibrillation using current Canadian Practice Guidelines supplemented with reassuring “Real World” experience.
  2. Assess and optimize bleeding risk of atrial fibrillation patients requiring long-term DOAC stroke prevention treatment.
  3. Recognize the current treatment gap in Canada and take steps at ensuring appropriate dosage selection and long-term compliance with oral anticoagulation among AF patients.

Case 9: Optimizing the Use and Dosing of DOACs in Patients with AF: Upon completion of this activity, participants should be able to:

  1. Apply the rationale for the appropriate use and non-use of community-based observational data (real-world data) in clinical practice.
  2. Discuss real-world treatment patterns with OAC therapy.
  3. Effectively manage the use and dosing of OAC therapy in patients with AF

Date: Thursday, June 13, 2019

Location: North 54, 1493 3rd Avenue, Prince George, BC

Speaker: Dr. Philip Teal

Moderator: Dr. Haidar Hadi

Registration: 6:30 pm (dinner to follow)

RSVP: Val Bernales, Phone: 604-679-3066 Email: val.bernales@pfizer.com

Accreditation: This one-credit-per-hour Group Learning program has been certified by the College of Family Physicians of Canada and the British Columbia Chapter for up to 1.50 Mainpro+ credits. This program has received an educational grant and in-kind support from BMS/Pfizer Alliance Canada


Disclaimer: The CME Event Calendar contains information originating from other sources. While every attempt is made to ensure that all information is accurately referenced, we do not guarantee the accuracy, quality or CME accreditation of posted events. Before registering for this event, please refer to the provincially harmonized CME Policy regarding reimbursement requirements for courses and conferences.

Address:

North 54
1493 3rd Avenue
Prince George V2L 3G1
Canada

Email event link Print event details

SHARE THIS PAGE